SEC-sourced researchBeta
VSBC
VITASPRING BIOMEDICAL CO. LTD.
Company comparison ↗
Data passport
- CIK
- 0001697884
- Exchange
- OTC
- Business activity
- — · SIC 8731
- Financial inputs
- 6/6
- Filing date
- Sep 17, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| January 2025 | 0.0000 | Jun 17, 2026 |
| January 2026 | 0.0000 | Jun 17, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| January 2026 | 0.0000 | -415,368.0000 | -2,688.0000 | 14,676.0000 | 4,445,244.0000 | Jun 17, 2026 |
| January 2025 | 0.0000 | -774,922.0000 | -14,675.0000 | 14,378.0000 | 4,029,578.0000 | Jun 17, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $0 | January 2026 | Jun 17, 2026 | 10-K |
| Previous period revenueRevenues | $0 | January 2025 | Jun 17, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$415.37K | January 2026 | Jun 17, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$2.69K | January 2026 | Jun 17, 2026 | 10-K |
| Total assetsAssets | $14.68K | January 2026 | Jun 17, 2026 | 10-K |
| Total liabilitiesLiabilities | $4.45M | January 2026 | Jun 17, 2026 | 10-K |